Symphoxanthone and Celibixanthone as ACE2 Inhibitors against SARS-CoV-2 Using Molecular Docking, MM GBSA and Molecular Dynamics Studies

2026

View at publisher

Authors: M H.P. Dilhara, Ramachandren Dushanan, Rajendram Senthilnithy

DOI: 10.9734/sarjnp/2026/v9i1221

Cited by: 0

Fields of Study & Subjects

Computational Drug Discovery Methods SARS-CoV-2 and COVID-19 Research Cholinesterase and Neurodegenerative Diseases